Cardan Capital Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-38,551	Closed	-$4.39M	–	280
2021 Q1	$4.39M	Buy	+38,551	New	+$4.39M	0.53%	60